Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock
- PMID: 7743336
- DOI: 10.1097/00024382-199405000-00004
Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock
Abstract
Septic shock is characterized by surges of tumor necrosis factor-alpha (TNF-alpha) along with myocardial dysfunction and systemic hypotension. TNF-alpha promotes the release of immunoreactive endothelin (ET). Because TNF-alpha is elevated in septic shock, we hypothesized that elevated levels of endothelin can contribute to cardiac dysfunction and hypotension. We infused live Pseudomonas aeruginosa into anesthetized, hemodynamically monitored young swine and measured ET and TNF-alpha. Septic swine developed systemic arterial hypotension and had significantly elevated TNF-alpha (4.15 +/- .41 U/ml at 1 h versus .40 +/- .13 U/ml at time zero) compared to control animals. ET levels were significantly elevated at 4 h (52.38 +/- 12.88 pg/ml vs. 10.45 +/- 1.82 pg/ml at time zero) and correlated negatively with the decline in cardiac output. We then passively immunized swine using anti TNF-alpha prior to the induction of sepsis to examine if TNF played a central role in the release ET. The anti TNF-alpha effectively removed circulating TNF-alpha bioactivity in septic animals. Anti-TNF-alpha-treated animals did not develop significant systemic arterial hypotension and had significant attenuation in endothelin (19.01 +/- 4.18 pg/ml at 4 h compared to 52.38 +/- 12.88 pg/ml in septic animals at 4 h) which correlated with preservation of cardiac output. TNF-alpha may cause cardiac dysfunction in sepsis syndrome through increased release of ET.
Similar articles
-
Delayed tumor necrosis factor alpha blockade attenuates pulmonary dysfunction and metabolic acidosis associated with experimental gram-negative sepsis.Arch Surg. 1994 Jan;129(1):80-9. doi: 10.1001/archsurg.1994.01420250092012. Arch Surg. 1994. PMID: 8279944
-
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.Crit Care Med. 1999 Nov;27(11):2485-94. doi: 10.1097/00003246-199911000-00027. Crit Care Med. 1999. PMID: 10579269
-
Tumor necrosis factor. Alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury.Am Rev Respir Dis. 1991 May;143(5 Pt 1):1076-82. doi: 10.1164/ajrccm/143.5_Pt_1.1076. Am Rev Respir Dis. 1991. PMID: 2024817
-
Tumor necrosis factor: an updated review of its biology.Crit Care Med. 1993 Oct;21(10 Suppl):S415-22. Crit Care Med. 1993. PMID: 8403979 Review.
-
[Cytokines and antagonists in septic shock].Schweiz Med Wochenschr. 1993 Mar 20;123(11):480-91. Schweiz Med Wochenschr. 1993. PMID: 8386392 Review. French.
Cited by
-
Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):156-67. doi: 10.1007/s00210-002-0663-6. Epub 2003 Jan 18. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12595957
-
Attenuation of shock-induced inflammation in the rat liver depends on the time of TNF-alpha inhibition.J Mol Med (Berl). 1996 Jan;74(1):51-8. doi: 10.1007/BF00202072. J Mol Med (Berl). 1996. PMID: 8834770
-
Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670.Br J Pharmacol. 1995 Apr;114(7):1327-8. doi: 10.1111/j.1476-5381.1995.tb13351.x. Br J Pharmacol. 1995. PMID: 7606336 Free PMC article.
-
The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.Br J Pharmacol. 1995 Dec;116(8):3309-15. doi: 10.1111/j.1476-5381.1995.tb15140.x. Br J Pharmacol. 1995. PMID: 8719812 Free PMC article.
-
Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.Br J Pharmacol. 1996 May;118(1):198-204. doi: 10.1111/j.1476-5381.1996.tb15386.x. Br J Pharmacol. 1996. PMID: 8733596 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources